U.S. Health Care REITs Stock News

On November 12, 2025, Earnix announced a new integration with Verisk Analytics, bringing together Earnix's Price-It platform and Verisk's ISO Electronic Rating Content to streamline insurance pricing and compliance processes. This development is intended to help insurance carriers quickly adopt regulatory changes, reduce manual workloads, and automate impact analyses, potentially making Verisk Analytics a more valuable data partner in the insurance industry. We'll explore how this new...

Life Time Group Holdings (LTH) reported impressive third-quarter results this week, with both revenue and net income rising sharply year-over-year. Management also raised full-year earnings forecasts, reflecting ongoing growth and strong demand. See our latest analysis for Life Time Group Holdings. Life Time Group Holdings' latest business updates, including expansion of its CTR workout program and raised full-year earnings guidance, have kept momentum building. Despite a dip in share price...

In recent weeks, Jacobs Solutions announced several major contract wins, including appointment as a supplier to the U.K. Crown Commercial Service's Management Consultancy Framework, a nine-year wastewater operations contract in Jackson, Mississippi, and design service leadership for Riyadh’s landmark New Murabba development in partnership with AECOM. These high-profile public sector and international projects underscore Jacobs' expanding role in delivering integrated advisory, digital, and...

Red Cat Holdings reported past third-quarter financial results that missed analyst expectations, with sales of US$9.65 million and a net loss of US$16.02 million, and also lowered its full-year 2025 revenue guidance to between US$34.5 million and US$37.5 million. Despite signing a major expanded government contract and launching a new maritime division, Red Cat’s aggressive growth initiatives have yet to translate into profitability. We'll examine how the combination of lowered revenue...

Praxis Precision Medicines (PRAX) just announced it has aligned with the FDA on the regulatory path for its relutrigine program targeting rare pediatric epilepsies like SCN2A and SCN8A-DEEs. This development could open a path to a New Drug Application in early 2026. This is a key milestone considering there are currently no FDA approved therapies for these severe conditions. See our latest analysis for Praxis Precision Medicines. Shares of Praxis Precision Medicines are enjoying a resurgence,...

Coursera reported stronger Q3 results, underpinned by accelerated growth in its Consumer segment, improved cash conversion, and updated full-year revenue guidance. Management cited ongoing Consumer momentum, the integration of the ChatGPT app ecosystem, and a significant AI content partnership with Anthropic as key drivers behind these results. We'll examine how the new AI-driven product integrations could impact Coursera's broader investment narrative and future growth assumptions. Trump...

FactSet Research Systems announced in early November that its Board of Directors approved a regular quarterly cash dividend of US$1.10 per share, payable on December 18, 2025, to shareholders of record as of November 28, 2025. This decision comes after FactSet's recent quarterly earnings missed expectations, drawing mixed analyst reactions and drawing attention to both its challenges in organic growth and its advancements in AI integration. In light of FactSet's dividend affirmation...

Paycom Software (PAYC) announced third quarter results, showing revenue met expectations and EBITDA edged higher than projected. Even though full-year guidance was raised, investors responded to slower revenue growth compared to competitors. See our latest analysis for Paycom Software. Over the past year, Paycom Software’s share price has struggled, with a one-year total shareholder return of -23.96% and a recent 30-day share price return of -17.23%. This underscores fading momentum. Recent...

Autoliv (ALV) announced a 2% increase to its quarterly dividend for the fourth quarter of 2025, signaling ongoing financial confidence and a commitment to returning value to shareholders. See our latest analysis for Autoliv. After the dividend increase was announced, Autoliv’s share price has shown steady momentum, gaining more than 30% year-to-date and delivering a 26.78% total shareholder return over the past twelve months. The company’s new dividend builds on a strong track record and...

HCI Group reported its third quarter results, showing a clear jump in both revenue and net income compared to last year. For investors, these numbers could spark new interest in the company’s trajectory. See our latest analysis for HCI Group. HCI Group’s share price has surged 57.24% year-to-date and is up a remarkable 16.53% over the past three months, suggesting real momentum is building after its latest earnings beat. For long-term holders, total shareholder return over the last year...

Wondering if Broadcom is a bargain or overpriced? You are not alone, and it is the right question to ask as the stock continues to be a topic of hot debate. Despite a dip of 2.0% over both the last week and month, Broadcom has soared 47.6% year to date and an astounding 109.8% over the past year, far outperforming much of the market. Momentum has been fueled by ongoing enthusiasm for semiconductor stocks in the AI space, along with recent high-profile partnerships that have kept Broadcom in...

Globalstar reported record third-quarter revenue of US$73.85 million and reaffirmed full-year guidance, while also announcing a significant upgrade to its satellite ground infrastructure across Brazil to enhance connectivity and support next-generation IoT services. Despite improved revenues and major technology investments, investor sentiment remained cautious due to a substantial year-over-year net income decline and earnings per share moving from positive to slightly negative. We'll...

On November 3, 2025, Safety Insurance Group's Board of Directors approved a US$0.92 per share cash dividend for the fourth quarter, while also announcing third quarter earnings with revenue of US$326.62 million and net income of US$28.31 million, both higher compared to the previous year. The company's continued revenue and earnings growth, paired with an affirmed dividend, reflects a period of robust operational performance and shareholder focus. We'll examine how sustained earnings...

Federal Home Loan Mortgage (FMCC) shares moved slightly higher today, catching the attention of investors looking for value in the mortgage sector. After a modest daily gain, the stock’s momentum invites a closer look at recent performance. See our latest analysis for Federal Home Loan Mortgage. After a sharp rally this year, with a year-to-date share price return of 141.25%, Federal Home Loan Mortgage has experienced some turbulence lately. This is shown by a 16.1% drop over the past week...

WillScot Holdings (WSC) stock came under renewed pressure after the company reported weaker-than-expected results for the third quarter of 2025. The company also issued a cautious revenue outlook for the next quarter. See our latest analysis for WillScot Holdings. Despite steady expansion moves and a recent dividend affirmation, WillScot Holdings’ share price momentum has faded in 2025, with a one-year total shareholder return of -48.5% and a sharp year-to-date drop of -47.3%. While...

Investors in Rhythm Pharmaceuticals (RYTM) saw movement after news that the FDA extended its review of the company’s supplemental New Drug Application for IMCIVREE in acquired hypothalamic obesity. The agency cited a need for further sensitivity analyses of clinical data. See our latest analysis for Rhythm Pharmaceuticals. The FDA's request for additional clinical analyses might have caused a bout of uncertainty, but Rhythm Pharmaceuticals has still delivered an eye-catching year, with the...

Earlier this month, ADT Inc. reported third quarter 2025 earnings with revenue rising to US$1,297.95 million and net income climbing to US$145.13 million, while also affirming its quarterly dividend and updating full-year guidance expectations to US$5,075 million–US$5,175 million in total revenue. Additionally, the company completed a series of share repurchases totaling 63,200,000 shares for US$500 million under its buyback program announced in February, reflecting significant capital...

Earlier this month, PTC Therapeutics reported third quarter 2025 earnings, posting US$211.01 million in revenue and a net income of US$15.9 million, compared to a net loss a year earlier, and also narrowed its full-year revenue guidance to US$750 million to US$800 million. This marked a sharp turnaround in profitability for the company, highlighting improved operational performance and signaling a shift from persistent losses to positive quarterly earnings. We'll examine how PTC...

Evercore (EVR) has just brought Keith Prusek and Hugh Rabb on board as senior managing directors in its transportation investment banking group. This move marks the opening of a new office in Richmond, Virginia and signals fresh momentum in its expansion strategy. See our latest analysis for Evercore. With this leadership shakeup and a new Richmond office, Evercore’s momentum is turning heads. The share price is up 11.4% year-to-date, and while the 1-year total shareholder return is a modest...

Autodesk (ADSK) stock has been relatively steady with slight movements over the past week. This has attracted attention from investors who are looking for updates on its growth story. Many are watching how its recent growth trends might influence upcoming quarters. See our latest analysis for Autodesk. Autodesk’s stock has posted a modest share price return year to date, and while short-term moves have been mild, its total shareholder return over the past three years sits at an impressive...

Spyre Therapeutics (SYRE) drew attention after releasing encouraging interim results from its Phase 1 trial of SPY003, in addition to reporting a substantial year-over-year improvement in both quarterly and nine-month net losses. See our latest analysis for Spyre Therapeutics. On the heels of upbeat clinical trial news and a slimmer quarterly net loss, Spyre Therapeutics has seen momentum pick up, with a recent 90-day share price return of 38.7%. However, despite these gains, the one-year...

Lamar Advertising (LAMR) just posted its third quarter earnings, revealing higher sales than the same period last year, although net income slipped a bit for the quarter. For the first nine months, both sales and net income were up compared to 2024. See our latest analysis for Lamar Advertising. Following this earnings update, Lamar Advertising’s share price has gained momentum, delivering an 8.9% return over the past month and building steadily throughout the year. Long-term investors have...

Cencora recently announced plans to expand its pharmaceutical distribution network across the U.S., including opening new advanced distribution centers in Ohio and California, and greatly increasing specialty medicine storage capacity in Alabama, all with a focus on automation and growing specialty drug demand. This expansion comes as the company reported higher full-year sales and net income, a quarterly loss caused by a substantial goodwill impairment, and a 9% increase in its quarterly...

Abaxx Technologies (OTCPK:ABXX.F) has been in the spotlight following two key moves: a partnership with ARTEX AG to modernize asset trading and the launch of the Enwex German Wind Futures contract. These developments highlight Abaxx's expanding global reach and focus on market infrastructure innovation. See our latest analysis for Abaxx Technologies. After a year of eye-catching developments, Abaxx Technologies is drawing more attention from growth-minded investors. The 237.5% year-to-date...